What's Happening?
Elation Health has integrated the American Heart Association's PREVENT™ cardiovascular risk equations into its Clinical Insights AI tool. This integration, which became the new clinical standard in March 2026, includes chronic kidney disease as a risk factor
for the first time. The tool aims to improve the accuracy of cardiovascular risk assessments, which were previously overestimated by older models. By embedding these equations directly into the primary care workflow, Elation Health eliminates the need for manual data entry, saving clinicians time and reducing administrative burdens.
Why It's Important?
The integration of the AHA's PREVENT™ tool into Elation Health's system represents a significant advancement in medical technology, particularly in the field of cardiovascular risk assessment. This development is crucial as cardiovascular disease affects nearly half of American adults. By providing more accurate risk assessments, the tool can enhance patient care and decision-making. The integration also demonstrates the potential of AI in healthcare, streamlining processes and improving efficiency in clinical settings. This could lead to better health outcomes and reduced healthcare costs.
What's Next?
Elation Health's integration of the PREVENT™ tool is expected to set a precedent for other healthcare providers to adopt similar technologies. As the tool becomes more widely used, it could lead to a shift in how cardiovascular risk is assessed and managed in clinical practice. The success of this integration may encourage further innovations in healthcare technology, particularly in the use of AI to improve patient care. Additionally, the tool's ability to incorporate new risk factors like chronic kidney disease highlights the importance of continuously updating clinical standards to reflect the latest medical research.
